394 related articles for article (PubMed ID: 26308290)
1. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
[TBL] [Abstract][Full Text] [Related]
2. The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice.
Chuderland D; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Ron-El R; Shalgi R
J Clin Endocrinol Metab; 2013 Feb; 98(2):E258-66. PubMed ID: 23295464
[TBL] [Abstract][Full Text] [Related]
3. Reducing the Risk of OHSS by GnRH Agonist Triggering.
Casper RF
J Clin Endocrinol Metab; 2015 Dec; 100(12):4396-8. PubMed ID: 26513003
[TBL] [Abstract][Full Text] [Related]
4. The Dual Role of PEDF in the Pathogenesis of OHSS: Negating Both Angiogenic and Inflammatory Pathways.
Miller I; Chuderland D; Grossman H; Ron-El R; Ben-Ami I; Shalgi R
J Clin Endocrinol Metab; 2016 Dec; 101(12):4699-4709. PubMed ID: 27680872
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor regulation by human chorionic gonadotropin in granulosa cells.
Bar-Joseph H; Ben-Ami I; Ron-El R; Shalgi R; Chuderland D
Reproduction; 2016 Feb; 151(2):179-85. PubMed ID: 26612427
[TBL] [Abstract][Full Text] [Related]
6. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
7. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
[TBL] [Abstract][Full Text] [Related]
8. Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats.
Tungmahasuk D; Fungbun N; Laoharatchatathanin T; Terashima R; Kurusu S; Kawaminami M
J Reprod Dev; 2018 Apr; 64(2):129-134. PubMed ID: 29249775
[TBL] [Abstract][Full Text] [Related]
9. Hormonal regulation of pigment epithelium-derived factor (PEDF) in granulosa cells.
Chuderland D; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Komsky A; Satchi-Fainaro R; Eldar-Boock A; Ron-El R; Shalgi R
Mol Hum Reprod; 2013 Feb; 19(2):72-81. PubMed ID: 23075882
[TBL] [Abstract][Full Text] [Related]
10. Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome.
Cerrillo M; Pacheco A; Rodríguez S; Gómez R; Delgado F; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2011 Jun; 95(8):2517-9. PubMed ID: 21269615
[TBL] [Abstract][Full Text] [Related]
11. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.
van de Lagemaat R; Raafs BC; van Koppen C; Timmers CM; Mulders SM; Hanssen RG
Endocrinology; 2011 Nov; 152(11):4350-7. PubMed ID: 21896671
[TBL] [Abstract][Full Text] [Related]
12. GnRH agonist vs. hCG for triggering of ovulation--differential effects on gene expression in human granulosa cells.
Haas J; Ophir L; Barzilay E; Yerushalmi GM; Yung Y; Kedem A; Maman E; Hourvitz A
PLoS One; 2014; 9(3):e90359. PubMed ID: 24603682
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats.
Kitajima Y; Endo T; Manase K; Nishikawa A; Shibuya M; Kudo R
Fertil Steril; 2004 Mar; 81 Suppl 1():842-9. PubMed ID: 15019818
[TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
[TBL] [Abstract][Full Text] [Related]
15. The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle.
Haas J; Bassil R; Gonen N; Meriano J; Jurisicova A; Casper RF
Reprod Biol Endocrinol; 2018 May; 16(1):54. PubMed ID: 29843716
[TBL] [Abstract][Full Text] [Related]
16. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
[TBL] [Abstract][Full Text] [Related]
17. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
18. Effect of kisspeptin-54 on ovarian levels of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in an experimental model of ovarian hyperstimulation syndrome (OHSS).
Birinci H; Vatansever HS; Yüncü M
Reprod Fertil Dev; 2021 Nov; 33(16):799-809. PubMed ID: 34610858
[TBL] [Abstract][Full Text] [Related]
19. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
[TBL] [Abstract][Full Text] [Related]
20. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
